BridgeBio Oncology Therapeutics

Biopharmaceutical company focused on developing precision medicines for genetic diseases and cancers driven by clear genetic causes, with a pipeline spanning rare diseases and oncology.

Location
Palo Alto, California, USA
Founded
2015
Investors
1
Categories
biotech, oncology, genetic-diseases, precision-medicine, therapeutics

Investors

NameLocationTypeStagesPortfolio
Deerfield ManagementNew York, USAbiotech-focused
seedseries-a+3
3